eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2026-03-20 19 1 99 108 10.13005/bpj/3340 70873 article Yenny Kandarini 1 I Made Adi Narendranatha Komara 2 Department of Internal Medicine, Udayana University, Denpasar, Bali, Indonesia Department of Internal Medicine Resident, Udayana University, Denpasar, Bali, Indonesia Chronic kidney disease (CKD) is defined as kidney damage, structurally and/or functionally, that persists for more than three months. Continuous ambulatory peritoneal dialysis (CAPD) has several benefits compared to other renal replacement therapies (RRT), although the results are inconclusive. The objective of this review and meta-analysis was to evaluate the survival rate of CKD patients undergoing CAPD. A systematic search according to PRISMA 2020 guidelines was carried out through online databases for relevant studies evaluating the survival rate of CKD patients undergoing CAPD. The articles obtained were observational studies that had been adjusted to the inclusion and exclusion criteria. Newcastle Ottawa Scale (NOS) was used to assess the study quality. Analysis was carried out with Review Manager software v.5.4. 11 studies were obtained, most of which were retrospective cohort studies from China, with 3700 aged 7.6 to 74.1 years and follow-up durations ranging from 5 months to 18 months. Based on the analysis, the pooled survival rate in 1, 2, 3, 5, and 10 years was 91% (95% CI 82–96%), 73% (95% CI 60–83%), 63% (95% CI 44–78%), 63% (95% CI 40–82), and 73% (95% CI 38–92%) respectively. Heterogeneity was high across time points (I² 96%–99%). Egger's 2-year survival rate analysis test showed a significant publication bias risk (p=0.046). CKD patients who underwent CAPD had a survival rate of 91%, 73%, 63%, and 73% at 1, 2, 3, 5, and 10 years, respectively. https://biomedpharmajournal.org/vol19no1/survival-rate-of-chronic-kidney-disease-ckd-patients-undergoing-continuous-ambulatory-peritoneal-dialysis-capd-a-meta-analysis/ Chronic Kidney Disease (CKD) Clinical Epidemiology Continuous Ambulatory Peritoneal Dialysis (CAPD) Survival Rate